Helicos Biosciences
Helicos BioSciences Corporation was a publicly traded life science company headquartered in Cambridge, Massachusetts focused on genetic analysis technologies for the research, drug discovery and diagnostic markets. The firm's Helicos Genetic Analysis Platform was the first DNA-sequencing instrument to operate by imaging individual DNA molecules. In May 2010, the company announced a 50% layoff and a re-focusing on molecular diagnostics. After long financial troubles, in November 2010, Helicos was delisted from NASDAQ. On November 15, 2012, Helicos BioSciences filed for Chapter 11 bankruptcy.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
Helicos Biosciences
Helicos BioSciences Corporation was a publicly traded life science company headquartered in Cambridge, Massachusetts focused on genetic analysis technologies for the research, drug discovery and diagnostic markets. The firm's Helicos Genetic Analysis Platform was the first DNA-sequencing instrument to operate by imaging individual DNA molecules. In May 2010, the company announced a 50% layoff and a re-focusing on molecular diagnostics. After long financial troubles, in November 2010, Helicos was delisted from NASDAQ. On November 15, 2012, Helicos BioSciences filed for Chapter 11 bankruptcy.
has abstract
Helicos BioSciences Corporatio ...... germline genome-edited babies.
@en
founding year
Link from a Wikipage to an external page
Wikipage page ID
17,630,223
page length (characters) of wiki page
Wikipage revision ID
1,011,545,294
Link from a Wikipage to another Wikipage
founded
industry
Biotechnology
@en
logo
@en
name
Helicos Biosciences
@en
traded as
NASDAQ:HLCS
@en
wikiPageUsesTemplate
subject
comment
Helicos BioSciences Corporatio ...... led for Chapter 11 bankruptcy.
@en
label
Helicos Biosciences
@en
sameAs
closeMatch
wasDerivedFrom
isPrimaryTopicOf
name
Helicos Biosciences
@en